Active, not recruitingNo phase
Registry for Mayo Clinic Adult Congenital Heart Disease Control Population
Key facts
- Who runs it
- Mayo Clinic
- Where
- Rochester, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 66 people enrolled
- Started
- 6 Jan 2022
- Expected to end
- Dec 2026
- Type of study
- Observational
- Record updated
- 12 March 2026
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- BMI ≤ 30
- No current cardiac medications
- Systolic BP ≤ 140 mmHg
- Diastolic BP ≤ 90 mmHg
- Capacity to consent
Who cannot take part
- History of cardiovascular disease. eGFR < 30
- To be assessed via EMR screening
- Patient confirmation during screening visit
- Screening tests as applicable
- Current orthopedic limitations
Where in United States
- Mayo Clinic MinnesotaRochester, United StatesNo longer taking part
About the trial
What the trial wants to find out
This research study is being done to provide comparative data to the Mayo Clinic Adult Congenital Heart Disease Registry.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Control Population for the Mayo Clinic Adult Congenital Heart Disease Registry
- Record updated
- 12 March 2026